BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23349053)

  • 1. Fine characterization of the recurrent c.1584+18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene.
    Costantino L; Rusconi D; Soldà G; Seia M; Paracchini V; Porcaro L; Asselta R; Colombo C; Duga S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):619-25. PubMed ID: 23349053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis patients with the 3272-26A-->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane.
    Beck S; Penque D; Garcia S; Gomes A; Farinha C; Mata L; Gulbenkian S; Gil-Ferreira K; Duarte A; Pacheco P; Barreto C; Lopes B; Cavaco J; Lavinha J; Amaral MD
    Hum Mutat; 1999; 14(2):133-44. PubMed ID: 10425036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
    Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
    Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
    Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
    Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Strong TV; Smit LS; Nasr S; Wood DL; Cole JL; Iannuzzi MC; Stern RC; Collins FS
    Hum Mutat; 1992; 1(5):380-7. PubMed ID: 1284540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
    Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.
    Will K; Dörk T; Stuhrmann M; Meitinger T; Bertele-Harms R; Tümmler B; Schmidtke J
    J Clin Invest; 1994 Apr; 93(4):1852-9. PubMed ID: 7512993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy.
    Tuffery-Giraud S; Saquet C; Chambert S; Claustres M
    Hum Mutat; 2003 Jun; 21(6):608-14. PubMed ID: 12754707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.
    Chiba-Falek O; Kerem E; Shoshani T; Aviram M; Augarten A; Bentur L; Tal A; Tullis E; Rahat A; Kerem B
    Genomics; 1998 Nov; 53(3):276-83. PubMed ID: 9799593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel donor splice site characterized by CFTR mRNA analysis induces a new pseudo-exon in CF patients.
    Costantino L; Claut L; Paracchini V; Coviello DA; Colombo C; Porcaro L; Capasso P; Zanardelli M; Pizzamiglio G; Degiorgio D; Seia M
    J Cyst Fibros; 2010 Dec; 9(6):411-8. PubMed ID: 20875776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.
    Highsmith WE; Burch LH; Zhou Z; Olsen JC; Boat TE; Spock A; Gorvoy JD; Quittel L; Friedman KJ; Silverman LM
    N Engl J Med; 1994 Oct; 331(15):974-80. PubMed ID: 7521937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 32-bp deletion (2991del32) in the cystic fibrosis gene associated with CFTR mRNA reduction.
    Dörk T; Will K; Grade K; Krawczak M; Tümmler B
    Hum Mutat; 1994; 4(1):65-70. PubMed ID: 7524915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
    J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.
    Aznarez I; Zielenski J; Rommens JM; Blencowe BJ; Tsui LC
    J Med Genet; 2007 May; 44(5):341-6. PubMed ID: 17475917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events.
    Buratti E; Dhir A; Lewandowska MA; Baralle FE
    Nucleic Acids Res; 2007; 35(13):4369-83. PubMed ID: 17580311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a splice site mutation (2789 +5 G > A) associated with small amounts of normal CFTR mRNA and mild cystic fibrosis.
    Highsmith WE; Burch LH; Zhou Z; Olsen JC; Strong TV; Smith T; Friedman KJ; Silverman LM; Boucher RC; Collins FS; Knowles MR
    Hum Mutat; 1997; 9(4):332-8. PubMed ID: 9101293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
    Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
    Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation.
    Chiba-Falek O; Parad RB; Kerem E; Kerem B
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1998-2002. PubMed ID: 10351951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites.
    Lee M; Roos P; Sharma N; Atalar M; Evans TA; Pellicore MJ; Davis E; Lam AN; Stanley SE; Khalil SE; Solomon GM; Walker D; Raraigh KS; Vecchio-Pagan B; Armanios M; Cutting GR
    Am J Hum Genet; 2017 May; 100(5):751-765. PubMed ID: 28475858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.